Clinical Trials Browser

Hodgkin Disease, Lymphoma, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large B-Cell, Diffuse

Nasopharyngeal Carcinoma

Breast Neoplasms

Nasopharyngeal Carcinoma

Gallbladder Neoplasms, Cholangiocarcinoma

Urinary Bladder Neoplasms

Nasopharyngeal Carcinoma

Pancreatic Neoplasms

Lymphoma, Large B-Cell, Diffuse

Infiltrating Bladder Urothelial Carcinoma

Lung Neoplasms

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Locally Advanced Pancreatic Cancer

Osteosarcoma

Urinary Bladder Neoplasms

Leiomyosarcoma, Sarcoma

Lung Neoplasms

Advanced Biliary Tract Carcinoma

Pancreatic Neoplasms

Urinary Bladder Neoplasms

Hodgkin Disease, Recurrence

Pancreatic Neoplasms

Bile Duct Neoplasms, Cholangiocarcinoma

Biliary Tract Neoplasms

Neoplasm Metastasis

Advanced Biliary Tract Carcinoma

Pancreatic Neoplasms

Carcinoma, Transitional Cell

Brain Neoplasms, Breast Neoplasms

Pancreatic Neoplasms

Muscle Invasive Bladder Cancer (MIBC)

Carcinoma, Non-Small-Cell Lung

Cholangiocarcinoma

Triple Negative Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms

Biliary Tract Neoplasms, Cholangiocarcinoma

Pancreatic cancer, adult, Pancreatic Neoplasms

Neoplasm Metastasis, Pancreatic Neoplasms

Biliary Tract Neoplasms, Carcinoma

Hodgkin Disease, Recurrence

Cholangiocarcinoma

Cholangiocarcinoma

Bone Neoplasms, Melanoma, Osteosarcoma, Urologic Neoplasms

Metastatic Pancreatic Adenocarcinoma

Non-Muscle Invasive Bladder Neoplasms

Cholangiocarcinoma

Clinical Trials

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

The Efficacy and Safety of Trastuzumab Rezetecan (SHR-A1811) in HER2-Low Unresectable/Metastatic Breast Cancer Patients With Visceral Crisis

Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC

Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases

Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer

Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response

PANCREAS

Low Dose Epcoritamab Plus GemOx in R/R DLBCL

Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

GAIN-BCG

Phase I Nab-Paclitaxel Plus Gemcitabine With Proton Therapy for Locally Advanced Pancreatic Cancer (LAPC)

Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma

Intravesical Gem/Doce in Patients With NMIBC

A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions

Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy

Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma

Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer

LAP100

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

FIL_A-BEGEV

QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer

Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)

MAGNATE-S

CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers

LUNG-05

SWITCH

TACTIC

PANC

Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC

SOLARA

BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma

HARBOR

ctDNA Lung RCT

Anti-PD-1/PD-L1 Antibodies Plus Gemcitabine and Cisplatin for Advanced CCA

Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer

COMET

Adaptive Chemotherapy for the Treatment of Advanced Breast Cancer

Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer

ACPC

PLATINUM-CAN

Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma

Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery

Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer

A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma